SCWorx Sees 85% Stock Surge Amid SEC Filing News
By ATTN Desk · Editorial oversight: Sean Han
SCWORX CORP (WORX) Overview
SCWORX CORP (“SCWorx”) is a small-cap technology company traded on the NASDAQ under the ticker WORX. The company specializes in healthcare supply-chain interoperability and analytics, providing hospitals and health systems with a Materials Management Information System (MMIS) Item Master.
1. Corporate Profile
| Attribute | Detail |
|---|---|
| Name | SCWORX CORP (에스시웍스) |
| Ticker | WORX |
| Exchange | NASDAQ (NAS) |
| Sector | Hospitals & Health Care |
| Employee Count | 11–50 (per LinkedIn) |
| Headquarters | United States |
| Website |
Core Offering
- Item Master Clean-up & Normalization: Establishes a Single Source of Truth (SSOT) for product and service data.
- SCWorx Cubenix: Reporting and analytics platform that integrates purchase history, contracts, and spend analysis.
- Interoperability Solutions: Connects supply-chain, financial, and clinical systems for real-time decision support.
2. Recent Developments and News
- April 25, 2025: The SEC declared SCWorx’s Form S-1 registration statement effective, enabling a potential equity offering.
- May 15, 2025:
- Filed its Q1 2025 Form 10-Q, detailing quarterly financial results and Management Discussion and Analysis (MD&A).
- Filed a Schedule 13G/A reporting significant beneficial ownership stakes:
- Iroquois Capital Management, LLC: 148,609 shares (6.61% of class)
- Richard Abbe: 226,191 shares (9.75% of class)
- May 27, 2025: Stock price closed at $0.7461, up 85.37% intraday, on a volume of 27,559,472 shares.
3. Financial & Strategic Analysis
Key Financial Metrics (TTM, per Yahoo Finance)
| Metric | Value |
|---|---|
| Revenue | $2.99 million |
| Net Income (Avi. to Common) | –$1.14 million |
| Diluted EPS | –$0.89 |
| Profit Margin | –38.01% |
| Return on Assets | –12.47% |
| Return on Equity | –27.24% |
| Total Cash (MRQ) | $106,650 |
| Total Debt/Equity (MRQ) | 5.89% |
| Levered Free Cash Flow (TTM) | –$1.38 million |
| Market Cap (intraday) | $1.46 million |
| Price/Sales | 0.23× |
| Price/Book | 0.26× |
| Beta (5Y Monthly) | 2.36 |
Strategic Positioning
- The company focuses on data accuracy in healthcare supply chains, which are significant as supplies and services account for approximately 33% of hospital operating budgets.
- Real-time interoperability enables clients to negotiate contracts and manage purchases more effectively.
- The effective S-1 registration suggests plans for additional capital to support product development or market expansion.
4. Market Position & Industry Context
- Niche Segment: SCWorx targets supply-chain executives, CFOs, and CIOs within hospitals and health systems.
- Competitive Landscape: Competes with larger enterprise resource planning (ERP) and supply-chain software vendors, while differentiating itself through healthcare-specific data normalization.
- Stock Characteristics:
- 52-Week Range: $0.39 – $3.31
- Average Daily Volume: ~2.3 million shares
- High volatility (Beta 2.36) reflects the nature of stock trading and its potential for significant price movement.
tl;dr
- On April 25, 2025, the SEC declared SCWorx’s S-1 effective, permitting a potential equity offering.
- Q1 2025 10-Q and Schedule 13G/A filings on May 15, 2025, reported continued net losses (–$1.14 million) and insider ownership stakes of 6.61% and 9.75%.
- Shares increased by 85.37% to $0.7461 on May 27, 2025, attributed to trading activity.
- Upcoming catalysts include the potential use of S-1 proceeds for product upgrades or sales expansion and the next quarterly earnings release expected in mid-August 2025.